comparemela.com

Latest Breaking News On - Redmile group - Page 3 : comparemela.com

Alpha Teknova, Inc. (NASDAQ:TKNO) Short Interest Down 32.5% in May

Alpha Teknova, Inc. (NASDAQ:TKNO – Get Free Report) was the recipient of a significant decline in short interest in May. As of May 15th, there was short interest totalling 35,100 shares, a decline of 32.5% from the April 30th total of 52,000 shares. Approximately 0.3% of the company’s stock are sold short. Based on an […]

United-states
Florida
Alpha-teknova
Redmile-group
Alpha-teknova-inc
Fourworld-capital-management
Board-of-administration-florida-retirement-system
Fielder-capital-group
Conestoga-capital-advisors
Alpha-teknova-company-profile
Nasdaq
Get-free-report

Ardelyx, Inc. (NASDAQ:ARDX) Receives $12.81 Average Price Target from Analysts

Shares of Ardelyx, Inc. (NASDAQ:ARDX – Get Free Report) have been assigned a consensus recommendation of “Buy” from the nine analysts that are presently covering the firm, Marketbeat Ratings reports. Eight research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 12-month […]

United-states
Piper-sandler
Leerink-partnrs
Elizabetha-grammer
Virtu-financial
Redmile-group
Farallon-capital-management
Nasdaq
Securities-exchange-commission
Castleark-management
Ardelyx-inc
Get-free-report

RAPT Therapeutics, Inc. (NASDAQ:RAPT) Receives Average Rating of "Hold" from Analysts

RAPT Therapeutics, Inc. (NASDAQ:RAPT – Get Free Report) has received a consensus recommendation of “Hold” from the thirteen analysts that are currently covering the company, Marketbeat Ratings reports. Nine analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 12 month target price among […]

United-states
Leerink-partnrs
Vanguard-group-inc
Nasdaq
Rapt-therapeutics-inc
Entrypoint-capital
Cantor-fitzgerald
Therapeutics-company-profile
Therapeutics-inc
Acadian-asset-management
Jpmorgan-chase-co
Redmile-group

RAPT Therapeutics, Inc. (NASDAQ:RAPT) Receives Average Rating of "Hold" from Brokerages

RAPT Therapeutics, Inc. (NASDAQ:RAPT – Get Free Report) has earned an average rating of “Hold” from the thirteen ratings firms that are currently covering the stock, Marketbeat.com reports. Nine equities research analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 12-month price objective […]

United-states
Redmile-group
Entrypoint-capital
Therapeutics-company-profile
Barclays
Therapeutics-inc
Acadian-asset-management
Jpmorgan-chase-co
Vanguard-group-inc
Nasdaq
Rapt-therapeutics-inc

Scholar Rock (NASDAQ:SRRK) Shares Up 6.4%

Scholar Rock (NASDAQ:SRRK) Shares Up 6.4%
modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.

Piper-sandler
Raymond-james
Vanguard-group-inc
Redmile-group
Nasdaq
Scholar-rock-holding-corporation
Pricet-rowe-associates-inc
Scholar-rock-company-profile
Scholar-rock-holding-co
Bellevue-group
Scholar-rock-holding
Get-free-report
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.